Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00513123 · ClinicalTrials.gov registry record
Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia
A clinical trial of Cervical Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 100
- Enrollment target
- 5
- Study locations
NCT00513123 is a study of Cervical Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (82% lower). The trial reports 5 study locations across 3 states.
The verdict
NCT00513123, a study of Cervical Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 5
- Study locations
Study Summary
The overall objective of this study is to identify potential improvements for a noninvasive method of diagnosing dysplasia and neoplasia in the cervix using digital colposcopy for colposcopy for fluorescence spectroscopy. Other Objectives: * To measure digital fluorescence and reflectance images in vivo of sites in the human cervix. * To evaluate the effect of acetic acid in the image contrast obtained. * Compare the device performance to colposcopy and pathologic analysis of tissue removed at colposcopy.
Conditions Studied
Interventions
- PROCEDURE Colposcopy
Study Locations (5)
Texas
- Lyndon B. Johnson Hospital - Houston
- U.T. Health Science Center - Houston
- U.T.M.D. Anderson Cancer Center - Houston
British Columbia
- British Columbia Cancer Research Center - Vancouver
Oyo State
- University College Hospital - Ibadan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2002-09 |
| Est. Completion | 2009-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00513123
The ClinicalTrials.gov registry entry for NCT00513123 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 570-participant average among 144 other Cervical Cancer trials with a reported enrollment target (82% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which Colposcopy is the first listed.
NCT00513123 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Texas, British Columbia, Oyo State.
Frequently Asked Questions
What is clinical trial NCT00513123 about?
NCT00513123 is a clinical study titled "Measurement of Digital Colposcopy for Fluorescence Spectroscopy of Cervical Intraepithelial Neoplasia". The overall objective of this study is to identify potential improvements for a noninvasive method of diagnosing dysplasia and neoplasia in the cervix using digital colposcopy for colposcopy for fluorescence spectroscopy. Other Objectives: * To measure digital fluorescence and reflectance images i...
What is the current status of trial NCT00513123?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2002-09. Estimated completion is 2009-02.
What conditions does trial NCT00513123 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT00513123?
The interventions under investigation include: Colposcopy (PROCEDURE).
Who is sponsoring clinical trial NCT00513123?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00513123 being conducted?
This trial has 5 study locations across Texas, British Columbia, Oyo State. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy
RECRUITING
-
PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
RECRUITING · Phase 2
-
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
RECRUITING · Phase 2
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
PopSci CHW4CervixHealth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.